Why Oscar Health, Inc.’s (OSCR) Stock Is Up 5.88%
As of Friday, August 14, Oscar Health, Inc.’s OSCR share price has surged by 5.88%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.
Commentary & Analysis
Which Is a Better Investment, Oscar Health, Inc. or Pelagos Insurance Capital Limited Stock?
Learn more about whether Oscar Health, Inc. or Pelagos Insurance Capital Limited is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Michael Rose
Which Is a Better Investment, F&G Annuities & Life, Inc. or Oscar Health, Inc. Stock?
Learn more about whether F&G Annuities & Life, Inc. or Oscar Health, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.Tudor Pop
Why Oscar Health, Inc.’s (OSCR) Stock Is Down 11.81%
As of Thursday, August 06, Oscar Health, Inc.’s OSCR share price has dipped by 11.81%, which has investors questioning if this is right time to buy.Jenna Brashear
What You Need to Know About Oscar Health, Inc.'s Q3 Earnings
Oscar Health, Inc.'s fiscal Q3 earnings report was released on Thursday, August 06. Let's dive in to see if (OSCR) missed or beat analyst's expectations.Michael Rose
Financial Summary
| Share Statistics | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $9,878.9 | $6,453.5 | 77% |
|
| Shares Out (Mil) | 333.4 | 66.0 | 84% |
|
| Institutional Ownership | 94.1% | 81.0% | 64% |
|
| Float (Mil) | 263.1 | 66.5 | 78% |
|
| Beta | 2.39 | 0.52 | 96% |
|
| Avg Daily Volume (000s) | 5,704 | 218 | 93% |
|
| Price Change (52-week) |
109.8% | 89.8% | 92% |
|
| Growth | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 97.3% | 5.8% | 98% |
|
| Net Income (5yr) | (1.7%) | 14.3% | 38% |
|
| EPS (5yr) | 34.6% | 15.6% | 85 |
|
| Dividends (5yr) | 0.0% | 3.1% | 0% |
|
| Cash Flow (5yr) | (22.2%) | (12.2%) | 29% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 9 | 8 | 9 | |
| Current EPS | ($0.246) | $1.751 | $1.882 | |
| Month Ago EPS | ($0.204) | $1.098 | $1.515 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | ($0.193) | $0.968 | $1.380 | |
| Year/Year Chg | (122.4%) | (203.6%) | (242.5%) | |
| Financials | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $15,319 | $5,268 | 88% |
|
| Net Income (TTM) (Mil) | $551 | $562 | 80% |
|
| EPS (TTM) | $1.927 | $2.500 | 71% |
|
| Operating Cash Flow (TTM) (Mil) | $4,419 | $632 | 94% |
|
| Net Cash Flow (TTM) (Mil) | $1,477 | $6 | 96% |
|
| Long-Term Debt (Q1) (Mil) | $482 | $917 | 58% |
|
| Enterprise Value (Q1) (Mil) | $4,941 | $7,912 | 63% |
|
| Valuation | OSCR | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.81 | 1.70 | 77% |
|
| P/E | 16.8 | 12.1 | 42% |
|
| Dividend Yield | 0.0% | 1.1% | 0% |
|
| PEG (5yr hist) | 0.5 | 0.5 | 23% |
|
| Ratios | OSCR | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 20.2% | 34.7% | 21% |
|
| Net Margin | 3.6% | 10.1% | 43% |
|
| ROA | 6.3% | 2.4% | 77% |
|
| ROE | 34.3% | 14.6% | 89% |
|
| Liabilities to Assets | 81.7% | 77.1% | 76% |
|
| F-Score | 6 | 6 | 67% |
|
Passing Stock Screens
As of 8/21/2026, from a list of 60 stock screening strategies,
FACTOR STRATEGY
Est Rev: Top 30 Up
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 21.5% |
| +/- S&P 500: | +14.0 |
FACTOR STRATEGY
Est Rev: Up 5% Screen
Factors: Earnings Estimates
Introduction to the use of earnings estimates.
| Performance Since Inception: | 22.7% |
| +/- S&P 500: | +15.2 |
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
GURU STRATEGY
O'Shaughnessy: Growth Screen II
Factors: Value, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 15.1% |
| +/- S&P 500: | +7.6 |
